Last Updated: November 14, 2024
The Baxter International Inc. North Cove facility in Marion, NC was impacted by heavy rain and flooding associated with Hurricane Helene. Storm and flood damage has resulted in the closure of the manufacturing plan that primarily manufactures intravenous and peritoneal dialysis solutions.
Baxter is a major U.S. manufacturer of these products and reportedly produces 1.5 million units of IV solutions daily, accounting for approximately 60 percent of the domestic United States production.
As of October 7, 2024, the Food and Drug Administration (FDA) has not declared a shortage of IV solutions because of the Baxter facility shutdown. The FDA and Baxter are however, strongly encouraging providers to assess existing IV solution product inventory, monitor usage rates, and explore a range of conservation strategies to preserve supplies in the current environment.
Learn more about this developing update, at: https://www.vdh.virginia.gov/emergency-medical-services/baxter-manufacturing-updates/
VDH Clinician Letter Updates
Disruption in Production of intravenous (IV) Fluid due to Impacts from Hurricane Helene- Update #3 – October 29, 2024
Disruption in Production of Intravenous (IV) Fluid Due to Impacts from Hurricane Helene—Update #2 – October 21, 2024
Update on Disruption in Production of Intravenous (IV) Fluid Due to Impacts from Hurricane Helene – October 8, 2024
Additional Info
Baxter Hurricane Helene Updates
HHS Informational Briefing on IV Fluid Conservation Best Practices | October 28, 2024